News Search News ... All Press Release Years All Years 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference May 18, 2022 DURECT Corporation Reports First Quarter 2022 Financial Results and Update of Programs May 4, 2022 DURECT Corporation to Announce First Quarter 2022 Financial Results and Provide Business Update on May 4 April 27, 2022 DURECT Corporation To Present at the 2022 Cantor Fitzgerald Virtual Rare Orphan Disease Summit March 23, 2022 DURECT Corporation Fireside Chat at the Oppenheimer 32nd Annual Healthcare Conference March 9, 2022 DURECT Corporation Reports Fourth Quarter and Full Year 2021 Financial Results and Update of Programs March 7, 2022 DURECT Corporation Doses First European Patient in Phase 2b AHFIRM Study of Larsucosterol(DUR-928) in Severe Alcohol-Associated Hepatitis March 1, 2022 DURECT Corporation to Announce Fourth Quarter and Full Year 2021 Financial Results and Provide Business Update on March 7 February 28, 2022 DURECT Corporation to Participate in H.C. Wainwright Bioconnect Conference January 6, 2022 DURECT and Innocoll Announce a $136 Million U.S. Licensing Agreement for POSIMIR® (Bupivacaine Solution) December 22, 2021
